Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P29
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-23.55%
202428.15%
202321.09%
202244.27%
2021103.54%
2020-35.01%
201975.69%
20182419.78%
2017-116.94%
2016171.24%